Cemin R - Search Results

1

[The ETNA-AF Europe registry: 4-year data of edoxaban use in atrial fibrillation in the Italian real world compared to the European cohort].

Riva L, Andò G, Anselmi M, Cemin R, Nassiacos D, Fionda G, De Caterina R; a nome dei Ricercatori ETNA-AF Europe (vedi Appendice). Riva L, et al. Among authors: cemin r. G Ital Cardiol (Rome). 2024 Nov;25(11):819-832. doi: 10.1714/0000.43289. G Ital Cardiol (Rome). 2024. PMID: 39450462 Italian.

2

[Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry].

De Caterina R, Renda G, Sangiuolo R, Attena E, Di Lecce L, Romeo F; Steering Committee del Registro Europeo PREFER in AF (vedi Appendice 1). De Caterina R, et al. G Ital Cardiol (Rome). 2014 Feb;15(2):99-109. doi: 10.1714/1424.15779. G Ital Cardiol (Rome). 2014. PMID: 24625849 Free article. Italian.

3

Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study.

Gussoni G, Di Pasquale G, Vescovo G, Gulizia M, Mathieu G, Scherillo M, Panuccio D, Lucci D, Nozzoli C, Fabbri G, Colombo F, Riva L, Baldo CI, Maggioni AP, Mazzone A; ATA-AF Steering Committee and Investigators. Gussoni G, et al. Eur J Intern Med. 2013 Jun;24(4):324-32. doi: 10.1016/j.ejim.2013.04.008. Epub 2013 May 16. Eur J Intern Med. 2013. PMID: 23684591

4

Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.

Berisso MZ, Fabbri G, Gonzini L, Caruso D, Fontanella A, Pellegrini F, Silvestri N, Vincenti A, Mathieu G, Di Pasquale G; ATA-AF Investigators. Berisso MZ, et al. J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):626-35. doi: 10.2459/JCM.0000000000000110. J Cardiovasc Med (Hagerstown). 2014. PMID: 24978662

5

[Heart failure in Italian intensive cardiac care units: data from the BLITZ-3 survey].

Chinaglia A, Casella G, Scorcu G, Cassin M, Chiarella F, Conte MR, Fradella G, Lucci D, Maggioni AP, Visconti LO; Ricercatori dello Studio BLITZ-3. Chinaglia A, et al. G Ital Cardiol (Rome). 2012 Jul-Aug;13(7-8):511-9. doi: 10.1714/1114.12247. G Ital Cardiol (Rome). 2012. PMID: 22781378 Italian.

6

Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation.

Proietti R, Gonzini L, Pizzimenti G, Ledda A, Sanna P, AlTurki A, Russo V, Lencioni M; ATA-AF Investigators. Proietti R, et al. Clin Cardiol. 2018 Dec;41(12):1570-1577. doi: 10.1002/clc.23065. Epub 2018 Dec 4. Clin Cardiol. 2018. PMID: 30144119 Free PMC article.

7

How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study.

De Luca L, Colivicchi F, Meessen J, Uguccioni M, Piscione F, Bernabò P, Lardieri G, Granatelli A, Gabrielli D, Gulizia MM; EYESHOT Post-MI Investigators. De Luca L, et al. Clin Cardiol. 2019 Nov;42(11):1113-1120. doi: 10.1002/clc.23262. Epub 2019 Aug 31. Clin Cardiol. 2019. PMID: 31471975 Free PMC article.

8

Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study.

De Luca L, Leonardi S, Cavallini C, Lucci D, Musumeci G, Caporale R, Abrignani MG, Lupi A, Rakar S, Gulizia MM, Bovenzi FM, De Servi S; EYESHOT Investigators. De Luca L, et al. Eur Heart J Acute Cardiovasc Care. 2015 Oct;4(5):441-52. doi: 10.1177/2048872614560505. Epub 2014 Nov 20. Eur Heart J Acute Cardiovasc Care. 2015. PMID: 25414322

9

[Distribution and appropriateness of hospital admissions, resource utilization in the Italian intensive cardiac care units. The BLITZ-3 study].

Visconti LO, Scorcu G, Cassin M, Casella G, Chinaglia A, Conte MR, Fradella G, Lucci D, Maggioni AP, Pirelli S, Chiarella F; Ricercatori del BLITZ-3. Visconti LO, et al. G Ital Cardiol (Rome). 2011 Jan;12(1):23-30. G Ital Cardiol (Rome). 2011. PMID: 21428024 Italian.

10

Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: insights from the EYESHOT study.

De Luca L, Leonardi S, Smecca IM, Formigli D, Lucci D, Gonzini L, Tuccillo B, Olivari Z, Gulizia MM, Bovenzi FM, De Servi S; EYESHOT Investigators. De Luca L, et al. Eur Heart J Cardiovasc Pharmacother. 2015 Jul;1(3):168-78. doi: 10.1093/ehjcvp/pvv006. Epub 2015 Feb 24. Eur Heart J Cardiovasc Pharmacother. 2015. PMID: 27533991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters